Neurogene (NGNE) Amortization of Deferred Charges (2014 - 2023)

Neurogene's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $304000.0 for Q3 2023.

• Quarterly Amortization of Deferred Charges rose 13.86% year-over-year to $304000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $1.2 million (up 13.96% YoY) and the FY2022 annual result came in at $1.1 million, up 8.24% from the prior year.
• Amortization of Deferred Charges was $304000.0 for Q3 2023 at Neurogene, up from $294000.0 in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $1.0 million in Q3 2020 and bottomed at $3000.0 in Q2 2020.
• A 4-year average of $312600.0 and a median of $265000.0 in 2021 frame the typical range for Amortization of Deferred Charges.
• Peak annual rise in Amortization of Deferred Charges reached 7533.33% in 2021, while the deepest fall reached 76.4% in 2021.
• Neurogene's Amortization of Deferred Charges stood at $252000.0 in 2020, then fell by 4.37% to $241000.0 in 2021, then grew by 14.11% to $275000.0 in 2022, then rose by 10.55% to $304000.0 in 2023.
• Business Quant data shows NGNE's Amortization of Deferred Charges at $304000.0 in Q3 2023, $294000.0 in Q2 2023, and $286000.0 in Q1 2023.